Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Gijsen

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Antibiotics (Basel, Switzerland)|June 24, 2022
Editorial for the Special Issue: "Therapeutic Drug Monitoring of Antimicrobials"Matthias Gijsen, Karel Allegaert
Intensive Care Medicine|December 17, 2024
Does artificial intelligence close gaps in clinical pharmacology in the ICU?Matthias Gijsen, Jan J De Waele
The Journal of Antimicrobial Chemotherapy|September 13, 2024
Oral antimicrobial agents in patients with short bowel syndrome: the importance of considering TDMBarbara Deleenheer, Matthias Gijsen, Isabel Spriet, et al.
Antibiotics (Basel, Switzerland)|October 23, 2021
Pharmacokinetics of Antibiotics in Pediatric Intensive Care: Fostering Variability to Attain Precision MedicineMatthias Gijsen, Dirk Vlasselaers, Isabel Spriet, et al.
Intensive Care Medicine|February 17, 2025
Continuous infusion of beta-lactam antibiotics in critically ill patients with sepsis: insights from daily clinical practiceIsabel Spriet, Matthias Gijsen, Marijke Peetermans, et al.
Intensive & Critical Care Nursing|February 28, 2024
A good start is half the battle: Antibiotic IV line residuals in the intensive care unitDorian Vanneste, Matthias Gijsen, Yves Debaveye, et al.
Critical Care (London, England)|June 20, 2020
Can augmented renal clearance be detected using estimators of glomerular filtration rate?Matthias Gijsen, Alexander Wilmer, Geert Meyfroidt, et al.
Intensive Care Medicine|March 18, 2022
The TARGET trial as a plea for model-informed precision dosing of piperacillin/tazobactam in patients with sepsisMatthias Gijsen, Erwin Dreesen, Joost Wauters, et al.
Therapeutic Drug Monitoring|December 11, 2024
Unbound Ceftriaxone Concentrations in Plasma Measured Using Ultrafiltration Versus Equilibrium DialysisMatthias Gijsen, Dorian Vanneste, Pieter Annaert, et al.
Frontiers in Pharmacology|May 28, 2020
Software Tools for Model-Informed Precision Dosing: How Well Do They Satisfy the Needs?Wannee Kantasiripitak, Ruth Van Daele, Matthias Gijsen, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Antibiotics (Basel, Switzerland)|June 24, 2022
Editorial for the Special Issue: "Therapeutic Drug Monitoring of Antimicrobials"Matthias Gijsen, Karel Allegaert
Intensive Care Medicine|December 17, 2024
Does artificial intelligence close gaps in clinical pharmacology in the ICU?Matthias Gijsen, Jan J De Waele
The Journal of Antimicrobial Chemotherapy|September 13, 2024
Oral antimicrobial agents in patients with short bowel syndrome: the importance of considering TDMBarbara Deleenheer, Matthias Gijsen, Isabel Spriet, et al.
Antibiotics (Basel, Switzerland)|October 23, 2021
Pharmacokinetics of Antibiotics in Pediatric Intensive Care: Fostering Variability to Attain Precision MedicineMatthias Gijsen, Dirk Vlasselaers, Isabel Spriet, et al.
Intensive Care Medicine|February 17, 2025
Continuous infusion of beta-lactam antibiotics in critically ill patients with sepsis: insights from daily clinical practiceIsabel Spriet, Matthias Gijsen, Marijke Peetermans, et al.
Intensive & Critical Care Nursing|February 28, 2024
A good start is half the battle: Antibiotic IV line residuals in the intensive care unitDorian Vanneste, Matthias Gijsen, Yves Debaveye, et al.
Critical Care (London, England)|June 20, 2020
Can augmented renal clearance be detected using estimators of glomerular filtration rate?Matthias Gijsen, Alexander Wilmer, Geert Meyfroidt, et al.
Intensive Care Medicine|March 18, 2022
The TARGET trial as a plea for model-informed precision dosing of piperacillin/tazobactam in patients with sepsisMatthias Gijsen, Erwin Dreesen, Joost Wauters, et al.
Therapeutic Drug Monitoring|December 11, 2024
Unbound Ceftriaxone Concentrations in Plasma Measured Using Ultrafiltration Versus Equilibrium DialysisMatthias Gijsen, Dorian Vanneste, Pieter Annaert, et al.
Frontiers in Pharmacology|May 28, 2020
Software Tools for Model-Informed Precision Dosing: How Well Do They Satisfy the Needs?Wannee Kantasiripitak, Ruth Van Daele, Matthias Gijsen, et al.
Pageof 5